When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. New colorectal cancer blood test approved by FDA: What to know

   www.aol.com/colorectal-cancer-blood-test...

   Why did the FDA approve the new colon cancer blood test? On July 29, 2024, ... of caution about colorectal cancer screening options, ... of the most rapidly growing cancers in young people today ...

3. Immunotherapy Before Surgery Leads to Better Outcomes for ...

   www.aol.com/immunotherapy-surgery-leads-better...

   Treatment options for DMMR colorectal cancer can be tricky. On one hand, it tends to be more resistant to chemotherapy, but researchers have now been making inroads with immunotherapy. Major ...

4. A new type of bacteria was found in 50% of colon cancers ...

   www.aol.com/news/type-bacteria-found-50-colon...

   Colon cancer is the second-leading cause of cancer deaths in the United States and is expected to kill more than 53,000 people in the nation in 2024, according to the American Cancer Society.

5. More young people are getting colon cancer. Avoid these 4 ...

   www.aol.com/news/more-young-people-getting-colon...

   Colon cancer will be diagnosed in approximately 150,000 Americans in 2024. It’s the fourth most diagnosed cancer in the United States and one of the leading causes of cancer deaths, according to ...

6. Colorectal cancer - Wikipedia

   en.wikipedia.org/wiki/Colorectal_cancer

   The signs and symptoms of colorectal cancer depend on the location of the tumor in the bowel, and whether it has spread elsewhere in the body ().The classic warning signs include: worsening constipation, blood in the stool, decrease in stool caliber (thickness), loss of appetite, loss of weight, and nausea or vomiting in someone over 50 years old. [15]

7. FOLFOX - Wikipedia

   en.wikipedia.org/wiki/FOLFOX

   Adjuvant treatment in patients with stage III colon cancer is recommended [2] for 12 cycles, every two weeks. The recommended dose schedule is as follows: Day 1: Oxaliplatin 85 mg/m 2 intravenous (IV) infusion in 250-500 mL D5W and leucovorin 200 mg/m 2 IV infusion in D5W administered concurrently over 120 minutes in separate bags using a Y-line, followed by fluorouracil (5-FU) 400 mg/m 2 IV ...